Viltolarsen Patent Expiration
Viltolarsen is Used for treating Duchenne Muscular Dystrophy in patients with a confirmed mutation that can be treated with exon 53 skipping. It was first introduced by Nippon Shinyaku Co Ltd
Viltolarsen Patents
Given below is the list of patents protecting Viltolarsen, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Viltepso | US10870676 | Antisense nucleic acids | Aug 31, 2031 | Nippon Shinyaku |
| Viltepso | US9079934 | Antisense nucleic acids | Aug 31, 2031 | Nippon Shinyaku |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Viltolarsen's patents.
Latest Legal Activities on Viltolarsen's Patents
Given below is the list recent legal activities going on the following patents of Viltolarsen.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 05 Jun, 2024 | US10870676 |
| transaction for FDA Determination of Regulatory Review Period | 08 Dec, 2023 | US9079934 |
| transaction for FDA Determination of Regulatory Review Period | 30 Nov, 2023 | US9079934 |
| Second letter to regulating agency to determine regulatory review period | 26 Jan, 2023 | US9079934 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 28 Dec, 2022 | US9079934 |
| Change in Power of Attorney (May Include Associate POA) Critical | 21 Dec, 2022 | US9079934 |
| Email Notification Critical | 21 Dec, 2022 | US9079934 |
| Email Notification Critical | 14 Nov, 2022 | US10870676 |
| Change in Power of Attorney (May Include Associate POA) Critical | 14 Nov, 2022 | US10870676 |
| Correspondence Address Change Critical | 30 Sep, 2022 | US10870676 |
Viltolarsen's Family Patents
